RPS6KB1 and liver cancer: The follow-up biochemical studies confirmed mTORC1 inactivation, as evidenced by reduced levels of p4E-BP1 and pS6K in both liver cancer cells and MEF cells upon UBE2F knockdown or knockout, respectively.